Oscar Health (NYSE:OSCR) CAO Sells $30,129.10 in Stock

Oscar Health, Inc. (NYSE:OSCR) CAO Victoria Baltrus sold 958 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $30,129.10. Following the sale, the chief accounting officer owned 213,631 shares of the company’s stock, valued at approximately $6,718,694.95. This represents a 0.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Trading Up 2.4%

NYSE:OSCR opened at $32.53 on Friday. The stock has a market cap of $10.04 billion, a price-to-earnings ratio of 23.24, a PEG ratio of 0.65 and a beta of 2.37. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The company’s 50 day moving average price is $30.58 and its 200-day moving average price is $23.27. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $33.55.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70. The company had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The firm’s revenue for the quarter was up 70.4% on a year-over-year basis. During the same period in the previous year, the business earned ($0.89) EPS. On average, equities research analysts forecast that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds have recently added to or reduced their stakes in OSCR. Jones Financial Companies Lllp lifted its holdings in shares of Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares during the period. Strs Ohio bought a new stake in shares of Oscar Health in the first quarter worth $30,000. Fifth Third Bancorp increased its position in Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after acquiring an additional 1,413 shares during the last quarter. CoreCap Advisors LLC increased its position in Oscar Health by 526.3% during the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after acquiring an additional 1,000 shares during the last quarter. Finally, Quarry LP lifted its holdings in Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after acquiring an additional 1,469 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on OSCR shares. Wells Fargo & Company boosted their price target on Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research note on Thursday, August 13th. Wall Street Zen raised Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Monday, July 6th. Piper Sandler reissued an “overweight” rating and issued a $36.00 target price on shares of Oscar Health in a research report on Tuesday, July 28th. Finally, Robert W. Baird set a $27.00 target price on shares of Oscar Health in a research note on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, Oscar Health presently has a consensus rating of “Hold” and a consensus price target of $26.22.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.

Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.